Weed (BUDZ) Gross Profit (2022)

Weed (BUDZ) posted quarterly Gross Profit of $2230.0 for Q4 2022, up 200.0% quarter-over-quarter from -$2230.0 in Q3 2022.

Weed (BUDZ) Gross Profit (2022) Analysis & Trends

Weed's Gross Profit history runs 1 years deep, the most recent figure standing at $2230.0 for Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Weed	3.13 Mn	3.13 Mn	-

Download Data